Robert Garcea
13Patents
2h-index
9Co-inventors
47Inventor score
Filing activity: May 6, 1991 → Sep 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6165471A | Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5213796A | Assay for polyomavirus in humans and uses thereof | Chemistry; Metallurgy | 10 | Expired |
| US10751408B2 | Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens | Chemistry; Metallurgy | 2 | Active |
| US7763259B2 | Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection | Chemistry; Metallurgy | 2 | Expired |
| US7279306B2 | Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US11364293B2 | Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens | Chemistry; Metallurgy | 1 | Active |
| US10413603B2 | Compositions, methods and uses for improved human papilloma virus constructs | Chemistry; Metallurgy | 1 | Active |
| US12303602B2 | Compositions, methods and uses for thermally stable multi-targeted antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US11806432B2 | Compositions, methods and uses for thermally stable multi-targeted antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US11273127B2 | Compositions, methods and uses for thermally stable multi-targeted antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US11185580B2 | Compositions, methods and uses for improved human papilloma virus constructs | Chemistry; Metallurgy | 0 | Active |
| US12186384B2 | Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens | Chemistry; Metallurgy | 0 | Active |
| US8039001B2 | Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.